The device supports a patient’s cardiac function, while the cardiac surgeon performs an angioplasty with reduced risk. During an angioplasty procedure, the heart is deprived of blood flow, which can result in heart failure or death. The Impella 2.5 ensures that blood flow is delivered to the body, which may prevent such negative outcomes. Additionally, a patient’s blocked arteries can be treated without the need for bypass surgery or even general anesthesia.
The Impella 2.5 can be inserted into the left ventricle in a catheterization lab via a standard guide wire through the femoral artery, into the ascending aorta, across the valve and into the left ventricle, generating flows up to 2.5 liters per minute. It is ideal for patients with decreased heart pumping function and who need revascularization – the opening of blood vessels to the heart. Most of these patients are considered high risk for open heart surgery or may not even be candidates for open heart surgery.